Results 141 to 150 of about 2,547 (172)
Some of the next articles are maybe not open access.
Bioresorbable polystatin fourth-generation stents
Coronary Artery Disease, 2013Stents have evolved through three generations, the latest of which are totally bioresorbable to include drugs targeting restenosis, the surface polymer eluting those drugs, and scaffolds on which those drugs are coated. These scaffolds, however, thus far, have been pharmacologically inactive and remain a potential site for delivering a second drug ...
Wayne H, Kaesemeyer +5 more
openaire +2 more sources
Bioresorbable Polymers and Stent Devices
Current Treatment Options in Cardiovascular Medicine, 2017Percutaneous coronary interventions will never become obsolete, as evolution is inherent to interventional cardiology. Current drug-eluting platforms have appreciably improved their safety and efficacy profiles in different clinical settings compared to first-generation devices such that it is difficult to consider other alternatives. However, there is
openaire +2 more sources
DRUG-ELUTING BIORESORBABLE STENTS FOR VARIOUS APPLICATIONS
Annual Review of Biomedical Engineering, 2006A stent is a medical device designed to serve as a temporary or permanent internal scaffold to maintain or increase the lumen of a body conduit. Metallic coronary stents were first introduced to prevent arterial dissections and to eliminate vessel recoil and intimal hyperplasia associated with percutaneous transluminal coronary angioplasty.
Meital, Zilberman, Robert C, Eberhart
openaire +2 more sources
The Bioresorbable Drug-Eluting Coronary Stent
JACC: Cardiovascular Interventions, 2017 exaly +2 more sources
Bioresorbable Stents: Is This Where We Are Headed?
Progress in Cardiovascular Diseases, 2015Current drug-eluting stents (DES) have shown excellent safety and efficacy in various clinical settings. However, the presence of a permanent metallic scaffold remains an Achilles heel, with concerns for late stent thrombosis and the need for prolonged dual anti-platelet therapy.
Siddharth A, Wayangankar +1 more
openaire +2 more sources
[The bioresorbable coronary stent: a revolution].
Revue medicale suisse, 2013Coronary angioplasty has undergone several technological revolutions: starting with balloon angioplasty, then with bare metal stent and finally with drug eluting stent (DES), this technique is now mature. However, once we thought the problem of instent restenosis solved with DES, new concerns arise with late and very late stent thrombosis.
Flora, Koegler, Edoardo, De Benedetti
openaire +1 more source
Clinical Research on Bioresorbable Stents
JOURNAL of CHITIN and CHITOSAN, 2023Eun Jung Jun, Jeongae Jo, Hyung Il Kim
openaire +1 more source
Fully Bioresorbable Vascular Stents
2023Sônia Maria Malmonge, Camila Cliquet
openaire +1 more source